HRSA, headquartered in this suburban Washington office building, would be empowered to audit 340B covered entities to see how they use income from 340B drug purchases, under a Biden administration proposal issued today.

Breaking News

HHS Wants to Audit 340B Providers to See How They Use 340B Net Income

The Biden administration this afternoon proposed amending the 340B statute to let federal health officials audit 340B covered entities “to determine how net income from purchases under [340B] are used by the covered entity.”

The proposed legislation is included in the administration’s fiscal year 2022 budget proposal for the U.S. Health and Human Services Department (HHS), which the White House issued today. It was not mentioned, however, in the U.S. Health Resources and Services Administration’s FY 2022 budget justification to Congress, also issued today. HRSA’s annual budget justification normally describes and explains proposed significant changes of this sort to the 340B program.

The Biden administration this afternoon proposed amending the 340B statute to let federal health officials audit 340B covered entities “to determine how net income from purchases under [340B] are used by the covered entity.”

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer